Condensed Consolidated Consolidated Statements Of Equity (Deficit) - USD ($) $ in Thousands |
Total |
Bridge Notes |
Common Stock warrants |
[1] |
Common Stock warrants
Merger
|
Retroactive application of the recapitalization |
Previously Reported |
Class A Common Stock |
Preferred Stock |
Adoption of accounting standards |
Adjusted balance |
Common Stock |
Common Stock
Bridge Notes
|
Common Stock
Common Stock warrants
|
[1] |
Common Stock
Common Stock warrants
Merger
|
Common Stock
Retroactive application of the recapitalization
|
Common Stock
Previously Reported
|
Common Stock
Class A Common Stock
|
Common Stock
Class A Common Stock
Retroactive application of the recapitalization
|
Common Stock
Class A Common Stock
Previously Reported
|
Common Stock
Class B Common Stock
|
Common Stock
Class B Common Stock
Retroactive application of the recapitalization
|
Common Stock
Class B Common Stock
Previously Reported
|
Common Stock
Preferred Stock
|
Common Stock
Adjusted balance
|
Common Stock
Adjusted balance
Class A Common Stock
|
Common Stock
Adjusted balance
Class B Common Stock
|
Additional Paid-in Capital |
Additional Paid-in Capital
Bridge Notes
|
Additional Paid-in Capital
Common Stock warrants
|
[1] |
Additional Paid-in Capital
Common Stock warrants
Merger
|
Additional Paid-in Capital
Retroactive application of the recapitalization
|
Additional Paid-in Capital
Previously Reported
|
Additional Paid-in Capital
Preferred Stock
|
Additional Paid-in Capital
Adjusted balance
|
Treasury Stock |
Treasury Stock
Retroactive application of the recapitalization
|
Treasury Stock
Previously Reported
|
Treasury Stock
Adjusted balance
|
Accumulated Deficit |
Accumulated Deficit
Retroactive application of the recapitalization
|
Accumulated Deficit
Previously Reported
|
Accumulated Deficit
Adoption of accounting standards
|
Accumulated Deficit
Adjusted balance
|
||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beginning balance, Carrying amount at Dec. 31, 2018 | $ 0 | $ (135,316) | $ 135,316 | |||||||||||||||||||||||||||||||||||||||||||||
Beginning balance, Shares outstanding (in shares) at Dec. 31, 2018 | 0 | (55,002,000) | 55,002,000 | |||||||||||||||||||||||||||||||||||||||||||||
Balance at beginning of period at Dec. 31, 2018 | $ 7,527 | $ 135,315 | $ (127,788) | $ 2 | $ 2 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ (1) | $ 1 | $ 145,179 | $ 122,815 | $ 22,364 | $ 0 | $ 12,500 | $ (12,500) | $ (137,654) | $ 0 | $ (137,654) | |||||||||||||||||||||||||||
Balance at beginning of period (in shares) at Dec. 31, 2018 | 15,481,000 | 15,481,000 | 0 | 0 | (16,825,000) | 16,825,000 | 0 | (83,987,000) | 83,987,000 | 0 | (11,500,000) | 11,500,000 | ||||||||||||||||||||||||||||||||||||
Stock-based compensation | 3,966 | 3,966 | ||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options | 121 | 121 | ||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock upon exercise of stock options (shares) | 146,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock on conversion (in shares) | 15,447,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock on conversion | 36,236 | $ 1 | 36,235 | |||||||||||||||||||||||||||||||||||||||||||||
Net loss | (66,145) | |||||||||||||||||||||||||||||||||||||||||||||||
Ending balance, Carrying amount at Dec. 31, 2019 | $ 0 | $ (171,321) | $ 171,321 | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||
Ending balance, Shares outstanding (in shares) at Dec. 31, 2019 | 0 | (76,971,000) | 76,971,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||||
Balance at end of period at Dec. 31, 2019 | $ (18,295) | $ 171,321 | $ (189,616) | $ (650) | $ (18,945) | $ 3 | $ 3 | $ 0 | $ 0 | $ (1) | $ 1 | $ 0 | $ (1) | $ 1 | $ 3 | $ 0 | $ 0 | 185,501 | 158,820 | 26,681 | $ 185,501 | $ 0 | $ 12,500 | $ (12,500) | $ 0 | (203,799) | 0 | (203,799) | $ (650) | $ (204,449) | ||||||||||||||||||
Balance at end of period (in shares) at Dec. 31, 2019 | 31,074,000 | 31,074,000 | 31,074,000 | 0 | 0 | (72,319,000) | 72,319,000 | 0 | (83,987,000) | 83,987,000 | 31,074,000 | 0 | 0 | 0 | (11,500,000) | 11,500,000 | 0 | |||||||||||||||||||||||||||||||
Stock-based compensation | $ 2,101 | 2,101 | ||||||||||||||||||||||||||||||||||||||||||||||
Issuance of subsidiary preferred stock (Note 16) | $ 3,247 | $ 3,247 | ||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options | 30 | 30 | ||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock upon exercise of stock options (shares) | 93,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon vesting of restricted stock awards (in shares) | 2,143,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock in connection with acquisition (in shares) | 55,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock issued during period (in shares) | 999,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Net loss | (9,145) | (9,145) | ||||||||||||||||||||||||||||||||||||||||||||||
Ending balance, Carrying amount at Sep. 30, 2020 | $ 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Ending balance, Shares outstanding (in shares) at Sep. 30, 2020 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Balance at end of period at Sep. 30, 2020 | $ (22,712) | $ 3 | $ 0 | $ 0 | 190,879 | $ 0 | (213,594) | |||||||||||||||||||||||||||||||||||||||||
Balance at end of period (in shares) at Sep. 30, 2020 | 34,364,000 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||
Beginning balance, Carrying amount at Dec. 31, 2019 | $ 0 | $ (171,321) | $ 171,321 | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||
Beginning balance, Shares outstanding (in shares) at Dec. 31, 2019 | 0 | (76,971,000) | 76,971,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||||
Balance at beginning of period at Dec. 31, 2019 | $ (18,295) | $ 171,321 | $ (189,616) | $ (650) | $ (18,945) | $ 3 | $ 3 | $ 0 | $ 0 | $ (1) | $ 1 | $ 0 | $ (1) | $ 1 | $ 3 | $ 0 | $ 0 | 185,501 | 158,820 | 26,681 | $ 185,501 | $ 0 | $ 12,500 | $ (12,500) | $ 0 | (203,799) | 0 | (203,799) | $ (650) | $ (204,449) | ||||||||||||||||||
Balance at beginning of period (in shares) at Dec. 31, 2019 | 31,074,000 | 31,074,000 | 31,074,000 | 0 | 0 | (72,319,000) | 72,319,000 | 0 | (83,987,000) | 83,987,000 | 31,074,000 | 0 | 0 | 0 | (11,500,000) | 11,500,000 | 0 | |||||||||||||||||||||||||||||||
Stock-based compensation | $ 2,390 | 2,390 | ||||||||||||||||||||||||||||||||||||||||||||||
Issuance of subsidiary preferred stock (Note 16) | $ 3,247 | $ 3,247 | ||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options | $ 30 | 30 | ||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock upon exercise of stock options (shares) | 188 | 188,000 | ||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon vesting of restricted stock awards (in shares) | 2,376,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock in connection with acquisition (in shares) | 55,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock issued during period (in shares) | 999,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Net loss | $ (19,535) | (19,535) | ||||||||||||||||||||||||||||||||||||||||||||||
Ending balance, Carrying amount at Dec. 31, 2020 | $ 0 | $ (174,568) | $ 174,568 | |||||||||||||||||||||||||||||||||||||||||||||
Ending balance, Shares outstanding (in shares) at Dec. 31, 2020 | 0 | (79,055,000) | 79,055,000 | |||||||||||||||||||||||||||||||||||||||||||||
Balance at end of period at Dec. 31, 2020 | $ (32,813) | $ 174,568 | $ (207,381) | $ 3 | $ 3 | $ 0 | $ 0 | $ (1) | $ 1 | $ 0 | $ (1) | $ 1 | 191,168 | $ 162,067 | $ 29,101 | $ 0 | $ 12,500 | $ (12,500) | (223,984) | $ 0 | $ (223,984) | |||||||||||||||||||||||||||
Balance at end of period (in shares) at Dec. 31, 2020 | 34,692,000 | 34,700,000 | 34,692,000 | 34,692,000 | 0 | 0 | (101,022,000) | 101,022,000 | 0 | (83,987,000) | 83,987,000 | 0 | (11,500,000) | 11,500,000 | ||||||||||||||||||||||||||||||||||
Stock-based compensation | $ 29,265 | 29,265 | ||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock due to Bridge Notes | 106,353 | $ 2 | 106,351 | |||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock due to Bridge Notes (in shares) | 20,343,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options | 100 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock upon exercise of stock options (shares) | 968,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon vesting of restricted stock awards (in shares) | 461,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock upon vesting of restricted stock units (in shares) | 102,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock on conversion (in shares) | 7,736,000 | 3,251,000 | 11,187,000 | |||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock on conversion | $ 77,097 | $ 2,289 | $ 38,329 | $ 1 | $ 1 | $ 77,096 | $ 2,289 | $ 38,328 | ||||||||||||||||||||||||||||||||||||||||
Issuance of sponsor earn-out shares | (17,659) | (17,659) | ||||||||||||||||||||||||||||||||||||||||||||||
Reverse recapitalization, net (in shares) | 34,584,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Reverse recapitalization, net (Note 4) | 200,874 | $ 4 | 202,152 | (1,282) | ||||||||||||||||||||||||||||||||||||||||||||
Net loss | (251,038) | (251,038) | ||||||||||||||||||||||||||||||||||||||||||||||
Ending balance, Carrying amount at Sep. 30, 2021 | $ 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Ending balance, Shares outstanding (in shares) at Sep. 30, 2021 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Balance at end of period at Sep. 30, 2021 | $ 152,797 | $ 11 | $ 0 | $ 0 | $ 629,090 | $ 0 | $ (476,304) | |||||||||||||||||||||||||||||||||||||||||
Balance at end of period (in shares) at Sep. 30, 2021 | 113,324,000 | 113,300,000 | 113,324,000 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||
Balance at beginning of period (in shares) at Sep. 08, 2021 | 31,625 | |||||||||||||||||||||||||||||||||||||||||||||||
Reverse recapitalization, net (in shares) | 34,584 | |||||||||||||||||||||||||||||||||||||||||||||||
Reverse recapitalization, net (Note 4) | $ 200,874 | |||||||||||||||||||||||||||||||||||||||||||||||
|